The patients that will avoid axillary lymph node dissection (ALND) meet all the criteria listed in the latest NCCN guidelines version.
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of T0-T1-T2 ER+/PR+ HER2- breast cancer with limited nodal involvement (1 or 2 suspicious lymph node on US, with at least 1 nodal positive cytology/histology)
M0
Conservative surgery or mastectomy
Neoadjuvant treatment not recommended after a multidisciplinary discussion
Patients between 18 and 90 years old
Patients willing and able to follow the study procedures and available for follow-up over the entire duration of the study
You may not be if
Psychiatric, addictive or any disorder, which compromises ability to give informed consent for participation in the study
Personal history of invasive breast cancer
Other invasive malignancies diagnosed in the last five years
Any condition that may expose the individual to a higher risk or preclude the study from achieving full compliance or completion
Contraindications to radiation therapy
Clareo Health | Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
